Myo Nyein AungSaiyud MoolphateDamodar PaudelMangalasiri JayathungeDuangjai DuangrithiKinley WangdiThin Nyein Nyein AungThaworn LorgaKazue HiguchiJuntendo University School of MedicineBoromarajonani College of NursingMahidol UniversityMid-western regional police hospitalJames Cook University, AustraliaRangsit UniversityPhuentshoting General HospitalUniversity of MedicineResearch Institute of Tuberculosis2018-10-192018-10-192013-03-01Journal of Infection in Developing Countries. Vol.7, No.3 (2013), 191-20219722680203665902-s2.0-84875172853https://repository.li.mahidol.ac.th/handle/20.500.14594/31960Tuberculosis (TB) and human immunodeficiency virus (HIV) co-epidemics form a huge burden of disease in the Southeast Asia region. Five out of eleven nations in this region are high TB/HIV burden countries: Myanmar, Thailand, India, Indonesia and Nepal. The trends of TB incidence in these countries have been rising in recent years, in contrast to a falling global trend. Experts in the field of TB control and health service providers have been perplexed by the association of TB and HIV infections which causes a mosaic clinical presentation, a unique course with poor treatment outcomes including death. We conducted a review of contemporary evidence relating to TB/HIV control with the aims of assisting integrated health system responses in Southeast Asia and demystifying current evidence to facilitate translating it into practice. © 2013 Aung et al.Mahidol UniversityImmunology and MicrobiologyMedicineReviewSCOPUS10.3855/jidc.2903